XML 59 R41.htm IDEA: XBRL DOCUMENT v3.21.4
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Q3) (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS [Abstract]    
Impact of Revision on Financial Statements
The impact of the revision on the Company’s financial statements is reflected in the following table.
 
As Previously
Reported
Adjustment
As Restated
Balance Sheet as of September 30, 2020 (unaudited)
 
 
 
Class A common stock subject to possible redemption
$113,348,455
$   18,901,545
$132,250,000
Class A common stock
$              189
$            (189)
$               —
Additional paid-in capital
$    5,414,035
$  (5,414,035)
$               —
Accumulated deficit
$     (414,554)
$ (13,487,321)
$(13,901,875)
Total Stockholders’ Equity (Deficit)
$    5,000,001
$ (18,901,545)
$(13,901,544)
Number of Class A common stock subject to possible redemption
11,334,808
1,890,192
13,225,000
 
As Previously
Reported
Adjustment
As Restated
Balance Sheet as of March 31, 2021 (unaudited)
 
 
 
Class A common stock subject to possible redemption
$111,657,920
$  20,592,080
$132,250,000
Class A common stock
$             206
$           (206)
$               —
Additional paid-in capital
$    7,104,553
$  (7,104,553)
$               —
Accumulated deficit
$  (2,105,081)
$(13,487,321)
$(15,592,402)
Total Stockholders’ Equity (Deficit)
$    5,000,009
$(20,592,080)
$(15,592,071)
Number of Class A common stock subject to possible redemption
11,165,366
2,059,634
13,225,000
 
 
 
 
Balance Sheet as of June 30, 2021 (unaudited)
 
 
 
Class A common stock subject to possible redemption
$109,288,323
$  22,961,677
$132,250,000
Class A common stock
$              230
$            (230)
$                —
Additional paid-in capital
$    9,474,126
$  (9,474,126)
$                —
Accumulated deficit
$  (4,474,677)
$(13,487,321)
$(17,961,998)
Total Stockholders’ Equity (Deficit)
$    5,000,010
$(22,961,677)
$(17,961,667)
Number of Class A common stock subject to possible redemption
10,928,252
2,296,748
13,225,000
 
 
 
 
Statement of Operations for the Period From July 14, 2020 (inception) through September 30, 2020 (unaudited)
 
 
 
Basic and diluted weighted average shares outstanding, Class A common stock
11,334,984
(9,978,574)
1,356,410
Basic and diluted net loss per share, Class A common stock
$                —
(0.10)
$          (0.10)
Basic and diluted weighted average shares outstanding, Class B common stock
2,684,663
234,568
2,919,231
Basic and diluted net loss per share, Class B common stock
$           (0.31)
$             0.21
$          (0.10)

 
As Previously
Reported
Adjustment
As Restated
Statement of Operations for the Three Months ended March 31, 2021 (unaudited)
 
 
 
Basic and diluted weighted average shares outstanding, Class A common stock
10,919,966
2,305,034
13,225,000
Basic and diluted net loss per share, Class A common stock
$               —
0.15
$            0.15
Basic and diluted weighted average shares outstanding, Class B common stock
5,611,284
(2,305,034)
3,306,250
Basic and diluted net loss per share, Class B common stock
$             0.44
$            (0.29)
$            0.15
 
 
 
 
Statement of Operations for the Three Months ended June 30, 2021 (unaudited)
 
 
 
Basic and diluted weighted average shares outstanding, Class A common stock
11,165,366
2,059,634
13,225,000
Basic and diluted net loss per share, Class A common stock
$               —
(0.14)
$          (0.14)
Basic and diluted weighted average shares outstanding, Class B common stock
5,365,884
(2,059,634)
3,306,250
Basic and diluted net loss per share, Class B common stock
$           (0.44)
$              0.30
$          (0.14)
 
 
 
 
Statement of Operations for the Six Months ended June 30, 2021 (unaudited)
 
 
 
Basic and diluted weighted average shares outstanding, Class A common stock
11,043,344
2,181,656
13,225,000
Basic and diluted net loss per share, Class A common stock
$                —
0.01

$            0.01
Basic and diluted weighted average shares outstanding, Class B common stock
5,487,906
(2,181,656)
3,306,250
Basic and diluted net loss per share, Class B common stock
$             0.02
$            (0.01)
$            0.01
 
 
 
 
Statement of Cash Flows for the Period From July 14, 2020 (inception) through September 30, 2020 (unaudited)
 
 
 
Supplemental non-cash disclosure: Initial classification of common stock subject to possible redemption
$113,349,840
$(113,349,840)
$                —
Supplemental non-cash disclosure: Change in value of common stock subject to possible redemption
$         (1,385)
$             1,385
$                —
Supplemental non-cash disclosure: Measurement adjustment of Class A common stock subject to redemption amount
$                —
$(13,511,990)
$(13,511,990)
 
As Previously
Reported
Adjustment
As Restated
Statement of Cash Flows for the three months ended March 31, 2021 (unaudited)
 
 
 
Supplemental non-cash disclosure: Change in value of common stock subject to possible redemption
$      2,458,260
$   (2,458,260)
$                —
 
 
 
 
Statement of Cash Flows for the six months ended June 30, 2021 (unaudited)
 
 
 
Supplemental non-cash disclosure: Change in value of common stock subject to possible redemption
$           88,663
$        (88,663)
$                —
 
 
 
 
Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the Period Ended September 30, 2020 (unaudited)
 
 
 
Sale of 13,225,000 Units, net of underwriter discounts and offering expenses
$  118,738,010
$(118,738,010)
$                —
Class A Common Stock subject to possible redemption
$(113,348,455)
$  113,348,455
$                —
Accretion for Class A Common Stock to redemption amount
$                  —
$  (13,511,990)
$(13,511,990)
 
 
 
 
Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the Three Months Ended March 31, 2021 (unaudited)
 
 
 
Class A Common Stock subject to possible redemption
$   (2,458,260)
$      2,458,260
$                —
 
 
 
 
Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the Three Months Ended June 30, 2021 (unaudited)
 
 
 
Class A Common Stock subject to possible redemption
$      2,369,597
$   (2,369,597)
$                —
The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash flows or cash.
 
As
Previously
Reported
Adjustments
As
Adjusted –
Restatement
No. 1
Balance sheet as of September 22, 2020 (unaudited)
 
 
 
Total Liabilities
$    4,848,750
$  10,682,000
$  15,530,750
Class A Common Stock Subject to Possible Redemption
124,031,840
(10,682,000)
113,349,840
Class A Common Stock
82
107
189
Additional Paid-in Capital
5,001,945
410,705
5,412,650
Accumulated Deficit
(2,352)
(410,812)
(413,164)
Total Stockholder’s Equity
5,000,006
5,000,006
Number of Class A common stock subject to redemption
12,403,184
(1,068,200)
11,334,984
 
 
 
 
Condensed Balance sheet as of September 30, 2020 (unaudited)
 
 
 
Total Liabilities
$    4,628,750
$  10,668,000
$  15,296,750
Class A Common Stock Subject to Possible Redemption
124,016,455
(10,668,000)
113,348,455
Class A Common Stock
82
107
189
Additional Paid-in Capital
5,017,330
396,705
5,414,035
Accumulated Deficit
(17,742)
(396,812)
(414,554)
Total Stockholder’s Equity
5,000,001
5,000,001
Number of Class A common stock subject to redemption
12,401,604
(1,066,796)
11,334,808
 
 
 
 
 
As
Previously
Reported
Adjustments
As
Adjusted –
Restatement
No. 1
Balance sheet as of December 31, 2020 (audited)
 
 
 
Total Liabilities
$    4,753,015
$  14,600,000
$  19,353,015
Class A Common Stock Subject to Possible Redemption
123,799,660
(14,600,000)
109,199,660
Class A Common Stock
85
146
231
Additional Paid-in Capital
5,234,122
4,328,666
9,562,788
Accumulated Deficit
(234,537)
(4,328,812)
(4,563,349)
Total Stockholder’s Equity
5,000,001
5,000,001
Number of Class A common stock subject to redemption
12,379,966
(1,460,000)
10,919,966
 
 
 
 
Condensed Statement of Operations for the Period From July 14, 2020 (inception) through September 30, 2020 (unaudited)
 
 
 
Net loss
$       (17,742)
$     (396,812)
$     (414,554)
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption
0.00
11,334,984
11,334,984
Basic and diluted net earnings per share, common stock subject to possible redemption
0.00
0.00
Weighted average non-redeemable common stock outstanding, basic and diluted
3,003,520
(318,857)
2,684,663
Basic and diluted net loss per non-redeemable common stock
(0.01)
(0.30)
(0.31)
 
 
 
 
Statement of Operations for the Period From July 14, 2020 (inception) through December 31, 2020 (audited)
 
 
 
Net loss
$     (234,537)
$  (4,328,812)
$  (4,563,349)
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption
12,401,730
(1,066,908)
11,334,822
Basic and diluted net earnings per share, common stock subject to possible redemption
0.00
0.00
Weighted average non-redeemable common stock outstanding, basic and diluted
3,612,953
627,593
4,240,546
Basic and diluted net loss per non-redeemable common stock
(0.06)
(1.02)
(1.08)
 
 
 
 
Condensed Statement of Cash Flows for the Period From July 14, 2020 (inception) through September 30, 2020 (unaudited)
 
 
 
Net loss
$       (17,742)
$     (396,812)
$     (414,554)
Change in fair value of warrant liabilities
(14,000)
(14,000)
Allocation of initial public offering costs
355,812
355,812
Other offering expense related to warrant liabilities
55,000
55,000
 
 
 
 
Statement of Cash Flow for the Year ended December 31, 2020 (audited)
 
 
 
Net loss
$     (234,537)
$  (4,328,812)
$  (4,563,349)
Change in fair value of warrant liabilities
3,918,000
3,918,000
Allocation of initial public offering costs
355,812
355,812
Other offering expense related to warrant liabilities
55,000
55,000
 
As
Previously
Reported
Adjustments
As
Adjusted –
Restatement
No. 1
Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the Period Ended September 30, 2020 (unaudited)
 
 
 
Sale of 13,225,000 Units, net of underwriting discounts and other offering costs
$  124,864,198
$ (6,126,188)
$  118,738,010
Class A Common Stock subject to possible redemption
$(124,016,455)
$10,668,000
$(113,348,455)
Sale of 4,145,000 Private Placement Warrants
$     4,145,000
$ (4,145,000)
$                 —
 
 
 
 
Statement of Changes in Stockholders’ Equity (Deficit) for the Period Ended December 31, 2020 (audited)
 
 
 
Sale of 13,225,000 Units, net of paid and deferred underwriting discounts
$ 124,864,198
$(6,126,188)
$ 118,738,010
Class A Common Stock subject to possible redemption
$(123,799,660)
$14,600,000
$(109,199,660)
Sale of 4,145,000 Private Placement Warrants
$     4,145,000
$ (4,145,000)
$                 —
The impact of the restatement on the Company’s financial statements is reflected in the following table.
 
As Previously
Reported per
Restatement No.1
Adjustment
As Adjusted –
Restatement
No.2
Balance Sheet as of September 22, 2020 (unaudited)
 
 
 
Class A common stock subject to possible redemption
$113,349,840
$  18,900,160
$132,250,000
Class A common stock
$              189
$            (189)
$                —
Additional paid-in capital
$    5,412,650
$ (5,412,650)
$                —
Accumulated deficit
$    (413,164)
$(13,487,321)
$(13,900,485)
Total Stockholders’ Equity (Deficit)
$    5,000,006
$(18,900,160)
$(13,900,154)
Number of Class A common stock subject to possible redemption
11,334,984
1,890,160
13,225,000
 
As Previously
Reported per
Restatement No.1
Adjustment
As Adjusted –
Restatement
No.2
 
 
 
 
Condensed Balance Sheet as of September 30, 2020 (unaudited)
 
 
 
Class A common stock subject to possible redemption
$113,348,455
$   18,901,545
$132,250,000
Class A common stock
$              189
$              (189)
$                —
Additional paid-in capital
$    5,414,035
$    (5,414,035)
$                —
Accumulated deficit
$     (414,554)
$  (13,487,321)
$ (13,901,875)
Total Stockholders’ Equity (Deficit)
$    5,000,001
$  (18,901,545)
$ (13,901,544)
Number of Class A common stock subject to possible redemption
11,334,808
1,890,192
13,225,000
 
 
 
 
Balance Sheet as of December 31, 2020 (audited)
 
 
 
Class A common stock subject to possible redemption
$109,199,660
$   23,050,340
$132,250,000
Class A common stock
$              231
$             (231)
$                —
Additional paid-in capital
$    9,562,788
$    (9,562,788)
$                —
Accumulated deficit
$  (4,563,349)
$  (13,487,321)
$ (18,050,670)
Total Stockholders’ Equity (Deficit)
$    5,000,001
$  (23,050,340)
$ (18,050,339)
Number of Class A common stock subject to possible redemption
10,919,966
2,305,034
13,225,000
 
 
 
 
Condensed Statement of Operations for the Period From July 14, 2020 (inception) through September 30, 2020 (unaudited)
 
 
 
Basic and diluted weighted average shares outstanding, Class A common stock
11,334,984
(9,978,574)
1,356,410
Basic and diluted net loss per share, Class A common stock
$                —
(0.10)
$           (0.10)
Basic and diluted weighted average shares outstanding, Class B common stock
2,684,663
234,568
2,919,231
Basic and diluted net loss per share, Class B common stock
$           (0.31)
$              0.21
$           (0.10)
 
 
 
 
Statement of Operations for the Period From July 14, 2020 (inception) through December 31, 2020 (audited)
 
 
 
Basic and diluted weighted average shares outstanding, Class A common stock
11,334,822
(3,555,410)
7,779,412
Basic and diluted net loss per share, Class A common stock
$               —
(0.42)
$           (0.42)
Basic and diluted weighted average shares outstanding, Class B common stock
4,240,546
(1,111,870)
3,128,676
Basic and diluted net loss per share, Class B common stock
$           (1.08)
$$
  0.66
$           (0.42)
 
 
 
 
Condensed Statement of Cash Flows for the Period From July 14, 2020 (inception) through September 30, 2020 (unaudited)
 
 
 
Supplemental non-cash disclosure: Initial classification of common stock subject to possible redemption
$113,349,840
$(113,349,840)
$                —
Supplemental non-cash disclosure: Change in value of common stock subject to possible redemption
$         (1,385)
$            1,385
$                —
Supplemental non-cash disclosure: Measurement adjustment of Class A common stock subject to redemption amount
$               —
$  (13,511,990)
$ (13,511,990)
 
 
 
 
 
As Previously
Reported per
Restatement No.1
Adjustment
As Adjusted –
Restatement
No.2
Statement of Cash Flows for the Period From July 14, 2020 (inception) through December 31, 2020
 
 
 
Supplemental non-cash disclosure: Initial classification of common stock subject to possible redemption
$ 113,349,840
$(113,349,840)
$               —
Supplemental non-cash disclosure: Change in value of common stock subject to possible redemption
$    (4,150,180)
$     4,150,180
$               —
Supplemental non-cash disclosure: Measurement adjustment of Class A common stock subject to redemption amount
$                 —
$  (13,511,990)
$(13,511,990)
 
 
 
 
Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the Period Ended September 30, 2020 (unaudited)
 
 
 
Sale of 13,225,000 Units, net of underwriter discounts and offering expenses
$  118,738,010
$(118,738,010)
$               —
Class A Common Stock subject to possible redemption
$(113,348,455)
$  113,348,455
$               —
Measurement Adjustment for Class A Common Stock to redemption amount
$                 —
$  (13,511,990)
$(13,511,990)
 
 
 
 
Statement of Changes in Stockholders’ Equity (Deficit) for the Period Ended December 31, 2020 (audited)
 
 
 
Sale of 13,225,000 Units, net of underwriter discounts and offering expenses
$  118,738,010
$(118,738,010)
$               —
Class A Common Stock subject to possible redemption
$(109,199,660)
$ 109,199,660
$               —
Measurement Adjustment for Class A Common Stock to redemption amount
$                 —
$  (13,511,990)
$(13,511,990)